{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 CEA Calibration Verification Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K143639",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140258"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 19, 2014",
    "Summary Letter Received Date": "December 22, 2014",
    "Submission Date": "January 20, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Carcinoembryonic antigen (CEA)"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2000 systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibration Verification Material",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE\u00ae 2000 CEA Calibration Verification Material used to verify calibration of IMMULITE CEA assay on IMMULITE 2000 systems",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration of the IMMULITE CEA assay on IMMULITE 2000 systems",
    "fda_folder": "Clinical Chemistry"
}